Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Sacconi

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|March 21, 2025
CircPVT1 weakens miR-33a-5p unleashing the c-MYC/GLS1 metabolic axis in breast cancerAlina Catalina Palcau, Claudio Pulito, Valentina De Pascale, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 24, 2020
TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patientsAndrea Sacconi, Sara Donzelli, Claudio Pulito, et al.
Cell Death Discovery|July 6, 2021
H-Ras gene takes part to the host immune response to COVID-19Salvatore Sciacchitano, Andrea Sacconi, Claudia De Vitis, et al.
Cell Death & Disease|January 10, 2019
Argonaute 2 drives miR-145-5p-dependent gene expression program in breast cancer cellsTeresa Bellissimo, Claudia Tito, Federica Ganci, et al.
Oncogenesis|February 16, 2020
microRNA-378a-5p iS a novel positive regulator of melanoma progressionMaria Grazia Tupone, Simona D'Aguanno, Marta Di Martile, et al.
Molecular Cancer|May 11, 2017
Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulationTeresa Bellissimo, Federica Ganci, Enzo Gallo, et al.
Scientific Reports|September 13, 2018
Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in vitro and in vivo modelLaura Belloni, Silvia Di Cocco, Francesca Guerrieri, et al.
Cancers|June 24, 2022
A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant SettingIrene Terrenato, Cristiana Ercolani, Anna Di Benedetto, et al.
Communications Biology|June 17, 2022
MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancerChiara Turco, Gabriella Esposito, Alessia Iaiza, et al.
British Journal of Haematology|July 28, 2021
MiR-22, a serum predictor of poor outcome and therapy response in diffuse large B-cell lymphoma patientsFederica Rinaldi, Francesco Marchesi, Francesca Palombi, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Journal of Experimental & Clinical Cancer Research : CR|March 21, 2025
CircPVT1 weakens miR-33a-5p unleashing the c-MYC/GLS1 metabolic axis in breast cancerAlina Catalina Palcau, Claudio Pulito, Valentina De Pascale, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 24, 2020
TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patientsAndrea Sacconi, Sara Donzelli, Claudio Pulito, et al.
Cell Death Discovery|July 6, 2021
H-Ras gene takes part to the host immune response to COVID-19Salvatore Sciacchitano, Andrea Sacconi, Claudia De Vitis, et al.
Cell Death & Disease|January 10, 2019
Argonaute 2 drives miR-145-5p-dependent gene expression program in breast cancer cellsTeresa Bellissimo, Claudia Tito, Federica Ganci, et al.
Oncogenesis|February 16, 2020
microRNA-378a-5p iS a novel positive regulator of melanoma progressionMaria Grazia Tupone, Simona D'Aguanno, Marta Di Martile, et al.
Molecular Cancer|May 11, 2017
Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulationTeresa Bellissimo, Federica Ganci, Enzo Gallo, et al.
Scientific Reports|September 13, 2018
Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in vitro and in vivo modelLaura Belloni, Silvia Di Cocco, Francesca Guerrieri, et al.
Cancers|June 24, 2022
A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant SettingIrene Terrenato, Cristiana Ercolani, Anna Di Benedetto, et al.
Communications Biology|June 17, 2022
MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancerChiara Turco, Gabriella Esposito, Alessia Iaiza, et al.
British Journal of Haematology|July 28, 2021
MiR-22, a serum predictor of poor outcome and therapy response in diffuse large B-cell lymphoma patientsFederica Rinaldi, Francesco Marchesi, Francesca Palombi, et al.
Pageof 12